Arquivamento definitivo - Art. 33 da LPI
#11.1.1
08/16/2022
RPI 2693
Application data
Number
112020016990Type
Filing
Publication
PCT
US2019018963 The application was abandoned: examination was not requested within the 36 months following the 02/21/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 08/16/2022. We update with every new RPI gazette, published weekly.
Applicants
FIVE PRIME THERAPEUTICS, INC.
US
Inventors
H. C. (pessoa física)
US
H. X. (pessoa física)
US
S. I. (pessoa física)
US
X. Z. (pessoa física)
US
IPC Classification
Priority claims
US
62/633,527 · 02/21/2018
US
62/802,100 · 02/06/2019
Abstract
A presente divulgação fornece métodos de administração de anticorpos e fragmentos de ligação ao antígeno deste que se ligam especificamente à B7-H4 humana a um sujeito em necessidade, por exemplo, um paciente com câncer.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
08/16/2022
RPI 2693
#11.1
05/31/2022
RPI 2682
#15.35
12/14/2021
RPI 2658
#1.3
02/23/2021
RPI 2616
#1.5
Apresente o relatório descritivo.
12/15/2020
RPI 2606
#1.1
10/20/2020
RPI 2598
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.